EnteroMedics aims to price public offering of common shares, warrants

Deal funds commercialization efforts, clinical and product development

By Devika Patel

Knoxville, Tenn., Feb. 21 - EnteroMedics Inc. said it expects to price a public sale of its common stock and warrants on Friday.

Craig-Hallum Capital Group LLC is the sole bookrunning manager.

Proceeds will be used to work towards regulatory approval of the Maestro RC System in the United States and for international commercialization efforts, clinical and product development activities and other working capital and general corporate purposes.

St. Paul-based EnteroMedics develops implantable systems for the treatment of obesity and other gastrointestinal disorders.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.